Business Context and Reporting Period
Company: QUALCOMM Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 28, 2003 (First Quarter of Fiscal 2004)
Business Overview: QUALCOMM designs, manufactures, and markets digital wireless telecommunications products and services based on CDMA technology. Operations are organized into four segments: QUALCOMM CDMA Technologies (QCT), QUALCOMM Technology Licensing (QTL), QUALCOMM Wireless & Internet (QWI), and QUALCOMM Strategic Initiatives (QSI).
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2004 | Q1 2003 |
|---|---|---|
| Total Revenues | $1,242.1 | $1,097.2 |
| Net Income | $352.3 | $241.3 |
| Diluted EPS | $0.43 | $0.30 |
| Operating Income | $510.2 | $446.7 |
| Cash from Operating Activities | $460.9 | $330.5 |
| Cash and Cash Equivalents (End of Period) | $1,795.9 | $1,620.3 |
| Total Assets | $9,033.4 | $8,822.4 |
| Long-Term Debt | $116.9 | $123.3 |
Revenue Breakdown: Equipment and services revenues were $888.5 million; Licensing and royalty fees were $353.6 million.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 13% year-over-year, driven by a 47% increase in licensing and royalty fees and a 4% increase in equipment and services.
- Profitability: Net income rose 46% to $352.3 million. Operating margin improved due to higher royalty revenues, partially offset by increased R&D spending and a significant loss on the sale of Vésper Operating Companies.
- Segment Performance:
- QCT: Revenues increased to $751.8 million; operating margin decreased to 35% from 41% due to higher R&D and SG&A expenses.
- QTL: Revenues surged to $353.4 million (up 38%) with an operating margin of 91%, driven by higher licensee phone sales volumes and average selling prices.
- QSI: Reported a loss before taxes of $67.3 million, primarily due to a $52 million net loss on the sale of Vésper Operating Companies.
- Investment Income: Net investment income improved significantly to $37.9 million from a net expense of $50.6 million in the prior year, largely due to the absence of $55 million in other-than-temporary losses on marketable securities recorded in Q1 2003.
Guidance, Outlook, and Risks
Management Commentary & Unusual Items:
- Vésper Disposition: The Company sold its interests in the Vésper Operating Companies in Brazil for no consideration in December 2003, recognizing a net loss of $52 million. The Company retained ownership of the communication towers (TowerCo) and expects to sell this interest in the near term.
- R&D Investment: R&D expenses increased to $150 million (12% of revenue) to support new product initiatives including CDMA2000 1xEV-DO, WCDMA/UMTS, and multimedia applications.
- Tax Rate: The effective tax rate for the quarter was 35%, higher than the estimated annual rate of 33% due to the tax impact of the Vésper sale.
Risks and Contingencies:
- Strategic Investments: The Company holds a significant investment in Inquam Limited ($69 million net) and has funding commitments for bridge loans. Inquam is not expected to be cash flow positive until 2007.
- Customer Concentration: The four largest customers accounted for 48% of consolidated revenues in Q1 2004.
- Legal Proceedings: Ongoing litigation includes patent disputes (e.g., Texas Instruments, Conexant) and employee-related class actions. The Company believes these claims are without merit and has not accrued liabilities.
- Market Risks: Exposure to foreign currency fluctuations and the success of CDMA technology adoption globally.
Investor Verification Checklist
- Vésper Transaction Details: Verify the status of the retained TowerCo assets and the timeline for their potential sale, as this could impact future earnings.
- Royalty Variance: Confirm the sustainability of the $57 million royalty variance recognized in the quarter, which resulted from licensee sales exceeding estimates.
- Inquam Exposure: Review the financial health of Inquam Limited and the likelihood of the Company needing to fund additional bridge loans or write down the investment.
- R&D Efficiency: Monitor whether the increased R&D spend ($150 million) translates into revenue growth in subsequent quarters, given the decline in QCT operating margins.
- Stock Repurchase Program: Note that $834 million remains authorized for stock repurchases, though no shares were repurchased in this quarter.